Schering Looking To Expand Therapeutic Frontiers Beyond Cholesterol

Schering-Plough is positioning itself to branch out from its cholesterol base into other therapeutic areas, CEO Fred Hassan said at the Morgan Stanley CEOs Unplugged investor conference on Jan. 4